Xcout IntelSign inSubscribe

Immobazyme

BiotechnologyCape Town, South Africa

Immobazyme is a biotechnology company headquartered in Cape Town, South Africa, specializing in enzyme engineering, recombinant protein production, and functional protein manufacturing.

Subscribe to see Immobazyme’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Immobazyme at a glance

Immobazyme is a biotechnology company headquartered in Cape Town, South Africa. It has raised at least $2.8M across the 2 funding rounds on record. Its most recent funding round, Growth, raised $1.4M in December 2025. Xcout tracks 19 named people at Immobazyme, including DOMINIC NICHOLAS (CEO FOUNDER).

As of 16 November 2026. Source: Xcout Intel.

Industry
Biotechnology
Headquarters
Cape Town, South Africa
Raised, rounds on record
$2.8M

Immobazyme leadership

  • DOMINIC NICHOLASCEO FOUNDER
  • DOMINIC NICHOLASCEO
  • ETHAN HUNTERCOO
  • NICK ENSLINCCO
  • Darrian LourensHead of Quality
  • Gabriele SchoemanHead of Marketing

13 more named people on record for Immobazyme, with roles, board committees and tenure — see the full roster →

Immobazyme funding rounds

At least $2.8M raised across the 2 rounds on record. Every round on record:

DateRoundAmountInvestors
Growth$1.4M3 named
Growth$1.3M3 named

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Who funded each Immobazyme round

A funding-flow diagram of the 5 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.

Sign in to see it, or subscribe for the full funding history →

Investors

Immobazyme competitors

A few of Immobazyme's closest competitors — see the full list of competitors and alternatives →

Codexis, Inc.CDXS · BiotechRedwood City, CA, United States
64% matchPublic

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications. Primarily serving pharmaceutical manufacturers, Codexis distributes its products through its dedicated direct sales and business development teams across the United States and Europe. Established in 2002, the company maintains its headquarters in Redwood City, California.

Market cap$104.9M
Employees188
Codexis, Inc. competitors & alternatives →

Get Immobazyme's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Immobazyme? Suggest a correction · Work at Immobazyme? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Immobazyme on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Immobazyme — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Immobazyme in Xcout Intel

  • 19 named people with titles, LinkedIn and board committees
  • 2 funding rounds with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →